Valiant Laboratories Limited (NSE:VALIANTLAB)
India · Delayed Price · Currency is INR 77.25
+1.28 (1.68%)
May 22, 2026, 3:25 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 4.18 billion as of May 22, 2026. Its market cap has decreased by -4.50% in one year.
Market Cap
4.18B
Enterprise Value
4.31B
Revenue
2.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
77.25
Market Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 4.18B, a decrease of -43.55%. That is a compound annual growth rate of -19.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 4.18B | 9.83% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Windlas Biotech | 16.67B |
| Jagsonpal Pharmaceuticals | 14.09B |
| Beta Drugs | 13.90B |
| Ind-Swift Laboratories | 11.74B |
| Sigachi Industries | 7.79B |
| Bafna Pharmaceuticals | 3.19B |
| Nectar Lifesciences | 2.37B |
| Brooks Laboratories | 1.51B |